Introduction
Amyotrophic lateral sclerosis (ALS) is the most common type of motor neuron disease characterized by the progressive degeneration of motor neurons in the brain and the spinal cord (Al-Chalabi et al, 2012; Cleveland & Rothstein, 2001) . ALS is a fatal neurodegenerative disease with no cure. Currently, there is only one FDA-approved drug for ALS. However, it is known to extend lifespan by only a few months (Costa et al, 2010) . Therefore, there is an urgent demand for the development of effective treatments for ALS.
Intracellular accumulation of TDP-43 is a pathological hallmark of ALS in the majority of cases (James et al, 2016; Josephs et al, 2017; Liscic et al, 2008; Scotter et al, 2015) . TDP-43 is a highly conserved nuclear RNA binding protein. So far, over fifty missense mutations of TDP-43 are linked to sporadic and familial ALS (Buratti, 2015; Scotter et al, 2015) . TDP-43-induced neurotoxicity is currently well recognized to contribute to the pathology of ALS and other neurodegenerative diseases linked to the deposition of TDP-43 called TDP-43 proteinopathy, such as Frontotemporal lobar
Methods

Reagents and Antibodies
The following reagents were purchased as indicated: dimethyl sulfoxide (DMSO) and mifepristone [Sigma]; MG132
[Calbiochem/Merck-Millipore]; PTK2 inhibitor (PF573228) and CK2 inhibitor (DMAT) [APExBIO]; ULK1 inhibitor (MRT68921) [Selleckchem] ; TBK1 inhibitor (BX 795) [Axon Medchem]. The following antibodies were used for immunoblotting: rabbit antiphospho-PTK2 (Tyr397) (catalog no. 3283), rabbit anti-PTK2 (catalog no. 3285), and HRP-conjugated anti-alpha-tubulin (catalog no. 9099) [Cell Signaling Technology] ; mouse anti-TBK1 (catalog no. ab40676); HRP-conjugated anti-mouse IgM (catalog no. ab97230), and rabbit anti-beta-actin (catalog no. ab16039) [Abcam] ; mouse anti-Polyubiquitin (FK1) (catalog no. BML-PW8805), [Enzo Life Science] ; rabbit anti-TDP-43 (catalog no. 10782-2-AP) [Proteintech] ; mouse anti-GFP (catalog no. 632380) [Clontech] ; rabbit anti-p62/SQSTM1 (catalog no. P0067) [Sigma] ; mouse anti-poly-ubiquitin (FK2) (catalog no. 04-263) [Calbiochem/Merck-Millipore] ; rabbit anti-phospho-p62 (Ser403) (catalog no. GTX128171) [GeneTex] ; mouse anti-turboGFP (catalog no. TA150041) [Origene] ; HRP-conjugated anti-rabbit IgG (catalog no. sc-2004) , and HRP-conjugated anti-mouse IgG (catalog no. sc-2005) [Santa Cruz] . The following antibodies were used for immunocytochemistry: rabbit anti-cleaved caspase-3 (catalog no. 9611) [Cell Signaling Technology] ; mouse anti-poly-ubiquitin (FK1) (catalog no. [Enzo Life Science]; rabbit anti-phospho-PTK2 (Tyr397) (catalog no. ab81298) [Abcam] ; mouse anti-DDK (catalog no. TA50011) [Origene] ; and rabbit anti-phospho-p62 (Ser403) (catalog no. GTX128171) [GeneTex] . The following antibodies were used for immunohistochemistry: rat anti-elav (catalog no. RAT-ELAV-7) [DSHB] and mouse anti-poly-ubiquitin (FK1) (catalog no. BML-PW8805) [Enzo Life Science] .
Cell lines
The SH-SY5Y human neuroblastoma cell line and Neuro-2a (N2a) mouse neuroblastoma cell line were maintained in DMEM (Life Technologies) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco) and penicillin-streptomycin (50 g/ml) (Gibco). Primary cultures of cerebral cortical neurons were prepared from 16-day embryonic mice as described previously (Araki et al, 2000; Enokido et al, 1992) .
Briefly, mouse embryos were decapitated, and the brains were rapidly removed and placed in a culture dish containing HBSS (Gibco). Cortices were isolated, transferred to a conical tube and washed twice in HBSS (Gibco). Cortical tissues were enzymatically digested by papain (20 units/ml) (Worthington Biochemical Corporation) and DNase I (0.005 %) for 30 min at 37 °C. The tissues were mechanically dissociated by gently pipetting up and down. The cortical cells were centrifuged at 800 rpm for 10 min at room temperature. Then, the dissociated cells were seeded onto plates coated with poly-Dlysine (Sigma-Aldrich) in neurobasal media containing 2 mM glutamine (Gibco), N2 supplement (Gibco), B27 supplement (Gibco), and penicillin-streptomycin (Gibco).
Culture media were changed initially after 5 days and then changed every 3 days. All experiments with primary neurons were performed at DIV 14-21 days.
Transfection N2a cells were plated in six-well plate and transfected with 4 µg of pCMV6-AC-TDP-43-GFP expressing green fluorescent protein (GFP)-tagged human TDP-43 per well by using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's guide. An empty pCMV6-AC-GFP plasmid was used as a negative control. For siRNA transfection, cells were transfected with control siRNA (Santa Cruz; sc-37007), mouse p62 siRNA (Santa Cruz; sc-29828), mouse ptk2 siRNA (Santa Cruz; sc-35353), or mouse tbk1 siRNA (Santa Cruz; sc-39059) by using Lipofectamine 3000 reagent. 48 h post-transfection, knockdown of target proteins was confirmed by immunoblot analysis.
Immunostaining For immunocytochemistry, cells were fixed in 4 % paraformaldehyde in PBS for 30 min. The following antibodies were used for immunostaining as indicated: mouse anti-poly-ubiquitin (FK1), rabbit anti-LC3, rabbit anti-PTK2 (Tyr397), rabbit anticleaved caspase-3, mouse anti-DDK, rabbit anti-phospho-p62 (Ser403), and rabbit antip62. Alexa-594 conjugated goat anti-rabbit IgG, Alexa-488 conjugated goat anti-mouse IgG, and Alexa-594 conjugated goat anti-mouse IgM (Jackson labs) were used as secondary antibodies as indicated. Antibodies were incubated in PBS with 0.3 % Triton and 1 % BSA. Then, samples were mounted and observed with a fluorescence microscope. For immunohistochemistry, adult flies were dissected in PBS and fixed in 4 % paraformaldehyde in PBS for 30 min. After incubating together with rat anti-elav (7E8A10) and mouse anti-poly-ubiquitin (FK1) in PBS with 0.3 % Triton and 5 % normal goat serum, the sections were incubated with Alexa-488 conjugated goat anti-rat IgG and Alexa-594 conjugated goat anti-mouse IgM (Jackson labs). All antibodies were diluted in PBS with 0.3 % Triton and 5 % normal goat serum. The samples were mounted and observed with fluorescence microscope or confocal microscope Proteasome activity assay N2a cells were transfected with pCMV6-AC-GFP or pCMV6-AC-TDP-43-GFP for 3 days and then the cells expressing GFP were sorted using FACS. Cells harvested were incubated in Lysis Buffer (25 mM HEPES (pH 7.4), 10 % glycerol, 5 mM MgCl 2 , 1 mM ATP, 1 mM DTT). The lysates were centrifuged at 13,000 × g for 30 min at 4°C. 100 g of total protein were used per proteasome purification by using 26S proteasome purification kit according to the manufacturer's guide (Enzo Life Science). The lysates were incubated with matrices (Enzo Life Science) for overnight at 4 ºC. 20S proteasome activity were measured using the 20S proteasome activity Kit (Enzo Life Science) according to the manufacturer's guide. Briefly, 20 g of purified lysates were incubated with inhibitor and enzyme matrix (Enzo Life Science) for 10 min at RT. After adding 10 µL of fluorescently labeled substrate (trypsin-like; Boc-LSTR-AMC, Bachem and chymotrypsin-like; Suc-LLVY-AMC; caspase-like; ZnLPnLD-AMC) to each well, the fluorescence signals were measured at 10-min intervals for 1 h using a FlexStation 3 microplate reader (set to 37 ºC, Molecular Devices) at an excitation wavelength of 360 nm and an emission wavelength of 460 nm.
Immunoblot analysis For total protein extraction, either cells or 20 adult fly heads were homogenized in RIPA buffer (Cell signaling Technology) or 1 × LDS sample buffer (Invitrogen) with protease and phosphatase inhibitor cocktails (Roche). The protein concentration of the cell lysates was determined by BCA protein assay (Pierce). Next, the protein extracts were mixed with NuPAGE LDS Sample buffer containing reducing agent and then boiled at 95 °C for 5 min. An equal amount of proteins from each sample were separated on NuPAGE 4-12 % Bis-Tris gels (Novex) or NuPAGE 3-8 % Tris-Acetate gels (Novex) and transferred to a polyvinylidene difluoride (PVDF; Novex) membrane.
After blocking membranes with 5 % skim milk in TBS with 0.025 % Tween 20, blots were probed with antibodies as indicated and detected with an ECL prime kit (Amersham Biosciences). Samples from three independent experiments were used and the relative expression levels were determined using a Fusion-FX (Viber Lourmat). 4 cells/ml), N2a cells (5 × 10 4 cells/ml), or primary cortical neuron cells (10 × 10 4 cells/ml) were grown in 96-well plates and treated with MG132 or inhibitors as indicated for 24 h. DMSO was used as a negative control.
Cytotoxicity Assay
To measure cytotoxicity, the Cell Counting Kit-8 (CCK-8; Enzo Life Science) was used according to the manufacturer's guide. Briefly, 10 µL of CCK-8 reagent was added into each well and the plate was incubated at 37 °C for 2 h. The absorbance at 450 nm was measured by using a microplate reader (Tecan). Cell viability was expressed as a percentage of control. All experiments were performed in triplicate. Fly strains Drosophila stocks were maintained on standard cornmeal agar media at 24 ºC unless otherwise noted. UAS-TDP-43 and UAS-ATXN2-32Q were described previously (Kim et al, 2014) . UAS-CL1-GFP has been described previously (Pandey et al, 2007) . All other stocks were from The Bloomington stock center.
Cyto-ID autophagy analysis
Climbing assays Adult males (0 to 1 day old) were separated and transferred into experimental vials containing fly media or paper mixed with or without RU-486 (in ethanol, 40 µg/ml) at a density of 25 flies per vial (n > 100). The number of dead flies was scored daily, and flies were transferred to fresh media or paper every other day.
Adult locomotor function was assessed by a previously described method (Feany & Bender, 2000) with 125 flies per genotype per time point in all experiments. Experiments were repeated twice to assure consistent results.
Results
TDP-43 overexpression induces UPS impairment
To see if TDP-43 overexpression impairs UPS in neuronal cells, we first transfected GFP-tagged human TDP-43 or negative control to mouse neuronal N2a cells (Fig. 1A ).
Consistent with previous findings (Bendotti et al, 2012) , TDP-43 overexpression dramatically increased accumulation of poly-ubiquitinated proteins in N2a cells compared to control (Fig. 1B) . TDP-43 overexpression markedly increased the levels of poly-ubiquitinated proteins in insoluble fractions, whereas it mildly increased the levels of poly-ubiquitinated proteins in soluble fractions (Fig. 1C ). To examine whether TDP-43 overexpression affects proteasome activity, we measured activities of 26S proteasomes purified from cell lysates. Interestingly, trypsin-like activity of the proteasomes from TDP-43-overexpressing cells was significantly decreased than that from control cells, whereas chymotrypsin-like activity was not altered by TDP-43 overexpression (Fig. 1D ).
It is well known that autophagy-lysosomal pathway (ALP) is activated upon UPS impairment as a compensatory mechanism (Wang & Wang, 2015) . In line with this, we also observed that TDP-43 overexpression activated ALP evidenced by increased levels of LC3 puncta and LC3-II/LC3-I ratio in N2a cells ( Fig. S1A and B) compared to control, further supporting that TDP-43 overexpression impairs UPS in neuronal cells. Taken together, our data demonstrated that TDP-43 overexpression decreases proteasome activity and thereby increases poly-ubiquitinated proteins in neuronal cells.
PTK2 inhibition ameliorates neurotoxicity induced by TDP-43 overexpression
Given that accumulation of poly-ubiquitinated proteins exerts a cytotoxic effects on cells, we hypothesized that UPS impairment may mediate neurotoxicity in TDP-43 proteinopathy, which may be attenuated by modulating deficits in UPS. To address this hypothesis, we screened molecules which regulate cytotoxicity induced by blocking UPS with MG132 through kinase inhibitor screening. We identified PF573228 as a potent suppressor of MG132-induced toxicity (Fig. S2 ). PF573228 is a PTK2-specific inhibitor 
PTK2 inhibition ameliorates UPS impairment and behavioral deficits in
Drosophila model of TDP-43 proteinopathy
Given strong in vitro evidence that PTK2 regulates TDP-43-induced toxicity in neuronal cells, we next examined whether inhibiting PTK2 suppresses TDP-43-induced toxicity in vivo using a Drosophila model of TDP-43 proteinopathy expressing human TDP-43 and ATXN2-32Q in the nervous system (hereafter referred to as TDP-P fly) (Elden et al, 2010; Kim et al, 2014) . The expression of TDP-43 in TDP-P flies was verified by Western blot (Fig. 3A) . We first assessed if UPS is impaired in TDP-P flies.
To monitor UPS activity in flies, we utilized CL1-GFP reporter flies expressing CL1 fused to GFP. CL1 degron is a peptide that is rapidly degraded specifically by the UPS.
Therefore, the level of CL1-GFP is indicative of UPS activity (Pandey et al, 2007) . The levels of CL1-GFP protein were markedly increased in TDP-P flies compared to controls (Fig. 3B) . Moreover, poly-ubiquitinated proteins were significantly increased in TDP-P fly heads (Fig. 3C ), suggesting that UPS is impaired in TDP-P flies.
To determine whether inhibiting PTK2 decreases poly-ubiquitinated proteins in TDP-P flies, we inhibited expression of Fak, the Drosophila homologue of PTK2, by
RNAi-mediated gene knock-down (Fig. 3D ). Inhibiting FAK dramatically decreased ubiquitin-positive aggregates in TDP-P flies (Fig. 3E) . Previously, we revealed that TDP-P flies showed deficits in climbing ability (Elden et al, 2010; Kim et al, 2014) . TDP-P flies showed a significant reduction of climbing ability at day 10 (Fig. 3F ). When FAK is inhibited, climbing ability was significantly improved in TDP-P flies compared to controls (Fig. 3F ). Taken together, PTK2 inhibition ameliorates UPS impairment and behavioral deficits in Drosophila model of TDP-43 proteinopathy
PTK2 inhibition ameliorates TDP-43-induced neurotoxicity in a p62-dependent manner
We next investigated how PTK2 regulates neurotoxicity in TDP-43 proteinopathy. It is noteworthy that inhibiting PTK2 markedly decreased ubiquitinated proteins under the condition that protein degradation via UPS is blocked (Fig. S2B) . However, PTK2
inhibition did not restore the impaired proteasome activity in TDP-43 overexpressed neuronal cells (Fig 1D) . Theses result suggest that PTK2 inhibition improves the mechanism of ubiquitinated protein degradation other than UPS. Ubiquitinated proteins can be degraded through ALP under the condition of UPS dysfunction (Korolchuk et al, 2010) . p62, also known as sequestosome 1 (SQSTM1), is an ubiquitin-binding protein that mediates degradation of poly-ubiquitinated proteins via ALP (Demishtein et al, 2017; Lippai & Low, 2014) . To see if p62 is involved in PTK2-mediated neurotoxicity under the condition of UPS dysfunction, we treated PTK2 inhibitor to MG132-treated cells with/without suppressing p62 by p62-specific siRNA (Fig. 4A ). Suppressing p62 completely abolished neuroprotective effect of PTK inhibition against MG132-induced toxicity in both N2a cells and primary neurons ( Fig. 4B and C).
We next investigated whether PTK2 regulates p62 under the condition of UPS dysfunction. Inhibiting PTK2 dramatically decreased the levels of phosphorylated p62 at Ser403 (p-p62 S403 ) without altering total p62 levels in N2a cells and primary neurons treated with MG132 ( Fig. 3D and E (Fig. 4F ).
The phosphorylation of p62 at Ser403 modulates its binding affinity to polyubiquitinated proteins, thereby regulating their autophagic degradation (Matsumoto et al, 2011) . To examine the effect of phosphorylation of p62 at Ser403 on the degradation of ubiquitinated proteins under the condition of UPS impairment, we generated stable N2a cell lines expressing wild type p62 and non-phosphorylated form of p62 (p62 S403A ) ( Fig.   S6A and B). p62 S403A -expressing cells showed significantly less poly-ubiquitin aggregates than p62-expressing cells under the condition of UPS impairment (Fig. 5A) , which was further validated by Western blot analyses ( Fig. S6C and D) . Moreover, p62 S403A -expressing cells showed significantly less co-localization of poly-ubiquitin aggregates with autophagic vesicles than p62-expressing cells (Fig. 5A) . Consistent with these results, p62 S403A -expressing cells showed more co-localization of p62 puncta with poly-ubiquitin aggregates than p62-expressing cells (Fig. 5B) , indicating that p62 phosphorylation at Ser403 inhibits degradation of poly-ubiquitinated proteins via ALP.
We next investigated whether p62 phosphorylation at Ser403 regulates TDP-43-induced neurotoxicity. To do this, we transfected TDP-43 or control to N2a cells expressing p62 or p62 S403A . Accumulation of poly-ubiquitinated aggregates by TDP-43 overexpression was markedly repressed in p62 S403A -expressing cells compared to p62-expressing cells (Fig. 5C ). In line with these, induction of caspase 3 expression by TDP-43 overexpression was strongly suppressed in p62 S403A -expressing cells compared to p62-expressing cells (Fig. 5D ). Taken together, our data suggest that PTK2 inhibition ameliorates TDP-43-induced neurotoxicity in a p62-dependent manner by repressing phosphorylation of p62 at Ser403.
PTK2 regulates p62 phosphorylation at Ser403 via TBK1
PTK2 is a tyrosine kinase which cannot phosphorylate p62 at Ser403. Therefore, another kinase should be involved in PTK2-mediated regulation of p62 phosphorylation.
Previous studies showed that Ser403 of p62 is phosphorylated by TANK-binding kinase 1 (TBK1), casein kinase 2 (CK2), or unc-51 like autophagy-activating kinase 1 (ULK1) (Lim et al, 2015; Matsumoto et al, 2011; Pilli et al, 2012) . Among those, only inhibiting TBK1 with BX797 rescued MG132-mediated neurotoxicity in SH-SY5Y cells (Fig. 6A ).
TBK1 inhibition with TBK1-specific siRNA showed similar protective effect against MG132-mediated neurotoxicity in primary neurons ( Fig. 6B and C) . TBK1 inhibition repressed MG-132-mediated induction of p62 S403 levels in primary neurons, without altering the levels of total p62, total PTK2, and p-PTK2 Y397 ( Fig. 6D and E) . Although it is not clear how PTK2 regulates TBK1 activity in neurons, out data suggest that PTK2
regulates neurotoxicity induced by UPS impairment by regulating TBK1-p62 axis in neurons.
Taken together, our data support a model whereby TDP-43 compromises UPS activity (Fig. 7) . Data are presented as the means ± SEM. *p<0.05, **p<0.005 (Student's t-test).
Genotypes: Control is elavGS,UAS-CL1-GFP/+, TDP-P is UAS-TDP-43/+;elavGS,UAS-
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